ALFA Filings
Every announcement, straight from the exchange
Every Dishman Carbogen Amcis earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Q1FY27 revenue fell 4.3% YoY to ₹6,776mn, with EBITDA margins dropping sharply to 8.9% due to CDMO project deferments and fixed costs.
Dishman Carbogen Amcis reported Q4 FY26 revenue of ₹851cr (up 19% YoY) and EBITDA of ₹163cr. Strategy focuses on high-margin ADC products and India site tech transfers.
Dishman Carbogen Amcis reported strong FY26 performance with revenue up 8.1% and EBITDA margins expanding to 19.3%. Growth is driven by CDMO and Vitamin D analogue segments.